$SCLX News

Scilex Announces Dividend Of 81.4M Dream Bowl Tokens To Stockholders; Launching Novel Digital Collectible Distribution Program

Scilex Holding Files Prospectus To Offer Up To $500M In Securities

Scilex Holding Makes $20M Strategic Investment In Quantum Scan Holdings To Identify, Develop, And Deploy Innovative Medical Technologies

Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments

Scilex Holding Company Appoints Kasowitz LLP as Litigation and Intellectual Property Counsel

Scilex Secures $100M Non-Recourse Loan From St. James Bank, Pledges 85.8M Datavault Shares As Collateral

Scilex Holding Company's (NASDAQ:SCLX) top owners are retail investors with 57% stake, while 24% is held by private companies

Scilex Secures Up To $50M Non-Recourse Loan From St. James Bank Secured By 39.2M Datavault AI Shares

Scilex Holding Company Announces Closing of Exercise of Warrants for $20.3 Million Gross Proceeds

ORMP: Advancing Clinical Activities, Generating Gains From Investment Portfolio, New Rights Plan Adopted

Scilex Holding Company Announces Exercise of Warrants for $20.3 Million Gross Proceeds

Scilex Raises $20M As Investors Exercise Stock Warrants To Support Non-Opioid Pain Drug Strategy

Scilex Holding Company Announces Update Regarding Distribution of Dream Bowl 2026 Meme Coin by Datavault AI Inc.

Datavault AI Sets November 25 Record Date For Dream Bowl 2026 Meme Coin Distribution To Equity Holders And Scilex Partners

Datavault AI Just Raised Guidance by 400%—Are You Paying Attention?

Oramed Reports Fiscal Third Quarter 2025 Financial Results

Datavault AI Reports 3Q-25 Highlights and Corporate Update

Datavault AI Board Approves Distribution Of Dream Bowl Draft Meme Coins To Eligible Holders Of Scilex Holding

Datavault AI Inc. Announces a $10M Worldwide Exclusive License Agreement with Scilex Holding Company for Tokenization and Monetization of Real-World Assets (RWA) in Genomic, DNA Data, Diagnostics, Therapeutics, Genetic, and Drug Information

Scilex Holding Company Announces Worldwide Exclusive License for Tokenization and Monetization of Real-World Asset (RWA) in Genomic, DNA Data, Diagnosis, Therapeutics Products, Genetic and Drug information from Datavault AI